InvestorsHub Logo
Followers 90
Posts 6401
Boards Moderated 0
Alias Born 08/14/2013

Re: None

Thursday, 01/21/2021 12:19:38 PM

Thursday, January 21, 2021 12:19:38 PM

Post# of 4556
Looks like news to me in reference to the conference call.

Hello Shareholders,
Thank you for calling in this morning, however, due to technical difficulties with our online Communications this morning we will have to cancel this meeting and reschedule it.
Based on my notes for this meeting, I have put together a quick summary to give an idea of the topics that I intended to cover.
As of today, we have received early voting in the amount of 184,170,822 votes, which is 55% of the required Quorum necessary to have an official shareholders meeting. Many of our shareholders are waiting until after the shareholders meeting to cast their votes.
The present tally is as follows:
-99% of the votes cast, voted yes, to keep myself, Joseph lastella as President.
-Over 96% voted yes, to issue a new class of Preferred Stock.
-Over 96% also voted yes to issue Preferred Stock for the exclusive rights to distribute Viro Spectrum Shield to 3 South American Countries with a population of approximately 300 million people i.e. Brazil, Peru, Colombia.
From the above voting statistics, it is obvious that all three resolutions will be passed at our next stockholder's meeting, provided we have the volume needed for a quorum vote. The stockholders
that voted so far, will not need to vote again because their votes are valid for 60 days. I urge everyone.
to keep us updated with their current email address so we can share information, send updates and
keep you informed about the progress of our company.
At the present time, our company is concentrating all its efforts on distribution of Viro Spectrum Shield, as it is of utmost importance that we help save lives during this active pandemic. COVID-19 is mutating quickly and spreading throughout the world. VSS has been successfully tested against multiple viruses, in particular tested at 99.9% efficacy against the COVID-19 virus in vitro .Results verified by a United States Federally Accredited lab prove that VSS is non-toxic and has shown Broad-Spectrum Antiviral capabilities that have never been seen before. Surprisingly, VSS is a proprietary herbal blend that is vegan, gluten free, kosher and last but not least an all-natural supplement, avoiding the risks associated with the current vaccines that use lab manufactured chemicals.
So many benefits to VSS, none more important than the fact that unlike the vaccines this formula can be used to treat the virus after infection as well as an all-natural preventative. Volunteers who were ill as a result of virus, many testing positive for the COVID-19 virus used VSS and showed reversal of symptoms in 24-72 hours. While the vaccines excluded anyone that was not a healthy adult, the VSS formula was used by all age ranges and levels of health, some with common health issues such as diabetes and autoimmune disorders. Please hear recent audio interviews at https://drive.google.com/file/d/1XKDtltbVZ9NkBJe__Oj-S3nRkFR-rBLf/view https://drive.google.com/file/d/12ldjTbYOuioBxnelHdA5reGc8nC5RJ_f/view and other testimonials at www.virospectrumshield.net. Keep up with our Blog on the GSPI website: www.gspiusa.com, where we share important, up to date information about COVID-19 and other industries we are involved with.
June of 2019 I was issued a patent for my industrial production process for making powdered Graphene, which became public knowledge with issuance by the US patent office. I have received many queries by shareholders regarding what the future holds for this patent. The Graphene industry is still in its infancy and open to unlimited opportunities, I will share my thoughts on the industry at our next shareholders meeting.
*Financials are undergoing final review and should be posted soon.
A sincere “Thank You” for being supportive of our company, we will notify everyone regarding the date of the next shareholders meeting which will be within 45 days of today.
Thank you for your support.
Joseph Lastella
President – GSPI

https://gspiusa.com/shareholders-meeting

$GSPI

Once a goal is complete, keep setting new and harder achievable goals.